The Silicon Review ^Asia

National Academy of Sciences has reported the development of a digitized biopsy, one that could be conducted in cancer clinics around the country. The scientists from the University of Illinois at Urban-Champaign have designed this model which is an alternative diagnostic tool.

"The advantage is that no stains are required, and both the organization of cells and their chemistry can be measured. Measuring the chemistry of tumor cells and their microenvironment can lead to better cancer diagnoses and a better understanding of the disease," said lead investigator Rohit Bhargava, a professor of bioengineering and the director of the Cancer Center at Illinois. This hybrid microscope technology will easily allow upgrading the image with better resolution.

The technique will give out infrared capabilities to the standard optical Microscope. This technique is also combined with machine learning algorithms, which will outperform the tedious and often subjective method of how the cancer diagnosis is done. The researchers hope that their innovation will allow the improvement of cancer cells. It is an intriguing invention in terms of pathology diagnoses. It could help the physicians to speed up the wait for results and will also provide an ‘all-digital’ solution for cancer pathology.